Pat Soon-Shiong: Allowing Immune System to Cure the Cancer
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of Los Angeles Times, shared a post on X:
“Exciting results in lung cancer today.
It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types.
This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location.
The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.”
Video Attached to the Post.
More posts featuring Pat Soon-Shiong.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023